Caring Brands, Inc. (Nasdaq: CABR) announced on September 2, 2026, that it has completed an initial closing under a $9 million Purchase Agreement. The company issued and sold $4.6 million in convertible preferred shares to certain accredited investors.
The filing indicates that the company expects to complete one or more additional closings on a rolling basis. As of the date of the report, an additional $4.4 million in subscription documents have been executed, and the company is awaiting the release of these funds. Upon receipt, the company plans to issue an additional 4,400 shares of Series B Preferred Stock, along with Series A and Series B warrants to purchase up to 4,400,000 shares of common stock each. The company expects these funds to be released and the securities issued on or before September 4, 2026, subject to closing conditions.
According to the company, the proceeds from the initial closing will be used to launch new Salesforce and marketing campaigns. Dr. Glynn Wilson, the Chief Executive Officer, stated that these moves are intended to enable the company to substantially increase revenues at a quicker pace.
Caring Brands Inc. is a wellness consumer-products company with a portfolio of unique, patented, and clinically validated products for skin and hair growth. The company intends to launch a total of five products over the next two years and is currently generating revenues from the sales of Hair Enzyme Booster and Photocil through direct sales in the US and licensees in India.
